DiaMedica Therapeutics Inc. — Director's Dealing 2019

Aug 19, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DiaMedica Therapeutics Inc. (DMAC)
CIK: 0001401040
Period of Report: 2019-08-16

Reporting Person: Pilnik Richard D. (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-08-16	Voting Common Shares, no par value per share	P	7840	$2.556	Acquired	50678	Direct

Footnotes

F1: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $2.5387 to $2.5775, inclusive. The reporting person undertakes to provide to Wright Medical Group N.V., any security holder of Wright Medical Group N.V., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote (1) to this Form 4.

F2: Includes 7,588 voting common shares issuable upon settlement of deferred share units granted under the DiaMedica Therapeutics Inc. Deferred Share Unit Plan.